Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Researchers Publish Findings Of A New Chemoprevention Gene Therapy That Kills Pancreatic Cancer Cells
http://www.medicalnewstoday.com/articles/117362.php
Researchers at the Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have published findings that implicate a new chemoprevention gene therapy (CGT) for preventing and treating pancreatic cancer, one of the most lethal and treatment-resistant forms of cancer.
Cancer Researchers And Oncologists Offer A Clinical Trial For Multiple Myeloma Patients
http://www.medicalnewstoday.com/articles/117354.php
Cancer researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine are studying the effects of experimental treatments on living tumor cells taken from multiple myeloma patients who are undergoing a routine diagnostic process.
Medarex Announces Allowance Of Investigational New Drug Application For Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
http://www.medicalnewstoday.com/articles/117329.php
Medarex, Inc. (Nasdaq: MEDX) announced the allowance of an investigational new drug application (IND) filed with the U.S. Food & Drug Administration (FDA) for MDX-1105, for the treatment of patients with selected advanced or recurrent solid tumors, specifically renal cell carcinoma, melanoma, non-small cell lung cancer or epithelial ovarian cancer.
New CyberKnife Technologies Demonstrate Dramatic Reduction In Treatment Times
http://www.medicalnewstoday.com/articles/117327.php
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that the first patients were treated using the next generation CyberKnife(R) Robotic Radiosurgery System that was recently installed at the Oklahoma CyberKnife, LLC in Tulsa, OK.
Perceived Discrimination Affects Screening Rates
http://www.medicalnewstoday.com/articles/116943.php
Minority men and women who perceived discrimination from their health care providers were less likely to be screened for colorectal or breast cancer, according to a report in the August issue of <i>Cancer Epidemiology, Biomarkers and Prevention</i>, a journal of the <a href="http://www.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Perceived Discrimination Affects Screening Rates
http://www.medicalnewstoday.com/articles/116943.php
Minority men and women who perceived discrimination from their health care providers were less likely to be screened for colorectal or breast cancer, according to a report in the August issue of <i>Cancer Epidemiology, Biomarkers and Prevention</i>, a journal of the <a href="http://www.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Leukemia Journal Publishes Results From Darinaparsin Study
http://www.medicalnewstoday.com/articles/117348.php
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced the publication of results from a pre-clinical study of darinaparsin (ZIO-101) in the July 17, 2008 on line advance publication issue of Leukemia, a <i>Nature</i> publication.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Exposure To Agent Orange Linked To Prostate Cancer In Vietnam Veterans
http://www.medicalnewstoday.com/articles/117365.php
UC Davis Cancer Center physicians released results of research showing that Vietnam War veterans exposed to Agent Orange have greatly increased risks of prostate cancer and even greater risks of getting the most aggressive form of the disease as compared to those who were not exposed.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment